X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1166) 1166
Publication (82) 82
Book / eBook (35) 35
Book Review (18) 18
Book Chapter (13) 13
Conference Proceeding (4) 4
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1000) 1000
ophthalmology (788) 788
male (642) 642
female (581) 581
vitreous body (482) 482
index medicus (465) 465
middle aged (452) 452
aged (432) 432
injections (349) 349
adult (298) 298
visual acuity (249) 249
bevacizumab (242) 242
vitrectomy (238) 238
treatment outcome (223) 223
fluorescein angiography (200) 200
diabetic retinopathy (194) 194
antibodies, monoclonal, humanized (192) 192
retrospective studies (190) 190
macular degeneration (181) 181
aged, 80 and over (177) 177
eye diseases (174) 174
follow-up studies (167) 167
surgery (167) 167
vascular endothelial growth factor a - antagonists & inhibitors (163) 163
tomography, optical coherence (155) 155
retina (154) 154
animals (144) 144
care and treatment (143) 143
intravitreal injections (141) 141
angiogenesis inhibitors - administration & dosage (139) 139
macular edema - drug therapy (127) 127
endothelial growth-factor (122) 122
vitreous body - drug effects (122) 122
diabetic retinopathy - drug therapy (121) 121
antibodies, monoclonal - administration & dosage (120) 120
prospective studies (120) 120
vascular endothelial growth factor (118) 118
injection (115) 115
vitreous hemorrhage - etiology (115) 115
ranibizumab (112) 112
angiogenesis inhibitors - therapeutic use (111) 111
diabetes (102) 102
genetic structures (101) 101
visual acuity - physiology (101) 101
vitreous hemorrhage (99) 99
research (96) 96
choroidal neovascularization - drug therapy (95) 95
sense organs (94) 94
glucocorticoids - administration & dosage (93) 93
vitreous body - pathology (92) 92
hemorrhage (91) 91
vitreous hemorrhage - drug therapy (89) 89
glucocorticoids - therapeutic use (88) 88
macular degeneration - drug therapy (84) 84
neovascularization (83) 83
avastin (80) 80
antibodies, monoclonal - therapeutic use (79) 79
fundus oculi (78) 78
vitreous body - metabolism (78) 78
diabetic retinopathy - surgery (77) 77
macular edema (76) 76
eye (75) 75
macular edema - etiology (75) 75
drug therapy (74) 74
triamcinolone (74) 74
rabbits (73) 73
retinal hemorrhage - drug therapy (73) 73
risk factors (73) 73
retinopathy (71) 71
patients (70) 70
management (69) 69
angiogenesis inhibitors - adverse effects (68) 68
triamcinolone acetonide - administration & dosage (68) 68
antibodies, monoclonal - adverse effects (66) 66
complications (66) 66
diabetic retinopathy - complications (66) 66
macular degeneration - complications (66) 66
retinal hemorrhage - etiology (66) 66
combined modality therapy (65) 65
therapy (63) 63
choroidal neovascularization (62) 62
intravitreal injection (62) 62
vitreous hemorrhage - surgery (62) 62
drug therapy, combination (61) 61
photodynamic therapy (60) 60
visual acuity - drug effects (60) 60
choroidal neovascularization - etiology (58) 58
eye diseases - drug therapy (57) 57
retinal diseases (55) 55
triamcinolone acetonide - therapeutic use (55) 55
edema (54) 54
postoperative complications (54) 54
retina - pathology (54) 54
time factors (54) 54
intravitreal bevacizumab (53) 53
hemorrhage - drug therapy (52) 52
medicine & public health (52) 52
safety (52) 52
endophthalmitis (51) 51
glaucoma (51) 51
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1119) 1119
German (20) 20
Russian (19) 19
French (17) 17
Polish (7) 7
Japanese (6) 6
Chinese (4) 4
Italian (4) 4
Spanish (4) 4
Czech (3) 3
Portuguese (2) 2
Dutch (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Retina, ISSN 0275-004X, 05/2016, Volume 36, Issue 5, pp. 938 - 943
Journal Article
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 03/2013, Volume 131, Issue 3, pp. 283 - 293
Journal Article
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 12/2010, Volume 248, Issue 12, pp. 1713 - 1718
Journal Article
Journal Article
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2013, Volume 156, Issue 3, pp. 524 - 531.e1
Purpose To evaluate the effect of intravitreal anti–vascular endothelial growth factor (VEGF) injections on submacular hemorrhage secondary to polypoidal... 
Ophthalmology | TISSUE-PLASMINOGEN ACTIVATOR | SUBRETINAL HEMORRHAGE | PHOTODYNAMIC THERAPY | INJECTION | OPHTHALMOLOGY | MACULAR DEGENERATION | INTRAVITREAL BEVACIZUMAB | PNEUMATIC DISPLACEMENT | NEOVASCULARIZATION | RANIBIZUMAB MONOTHERAPY | EXPANSILE GAS | Vitreous Hemorrhage - diagnosis | Polyps - diagnosis | Retinal Hemorrhage - etiology | Intravitreal Injections | Choroid Diseases - complications | Coloring Agents | Humans | Middle Aged | Male | Tissue Plasminogen Activator - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Photochemotherapy | Bevacizumab | Fibrinolytic Agents - therapeutic use | Ranibizumab | Angiogenesis Inhibitors - therapeutic use | Female | Retrospective Studies | Angiogenesis Inhibitors - adverse effects | Visual Acuity - physiology | Fluorescein Angiography | Macula Lutea - pathology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Tomography, Optical Coherence | Choroid - blood supply | Indocyanine Green | Treatment Outcome | Combined Modality Therapy | Polyps - complications | Aged | Choroid Diseases - diagnosis | Retinal Hemorrhage - drug therapy | Hemorrhage | Vascular endothelial growth factor | Care and treatment | Medical colleges | Endothelial growth factors | Analysis | Macular degeneration | Hospitals | Medical imaging | Colleges & universities | Myopia | Tomography | Patients | University colleges
Journal Article
Clinical & Experimental Ophthalmology, ISSN 1442-6404, 07/2008, Volume 36, Issue 5, pp. 449 - 454
Purpose:  Bevacizumab (Avastin) is a monoclonal antibody which targets all isoforms of vascular endothelial growth factor A. Its potent anti-angiogenic effects... 
vitreous haemorrhage | vitrectomy | proliferative diabetic retinopathy | Avastin | tractional retinal detachment | Vitrectomy | Vitreous haemorrhage | Tractional retinal detachment | Proliferative diabetic retinopathy | INTRAVITREAL BEVACIZUMAB AVASTIN | INJECTION | OPHTHALMOLOGY | MACULAR DEGENERATION | VITREOUS HEMORRHAGE | Retinal Detachment - etiology | Diabetic Retinopathy - drug therapy | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Retinal Detachment - drug therapy | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Retinal Detachment - surgery | Neovascularization, Pathologic - etiology | Vitreous Hemorrhage - etiology | Neovascularization, Pathologic - complications | Bevacizumab | Diabetic Retinopathy - complications | Diabetic Retinopathy - physiopathology | Antibodies, Monoclonal, Humanized | Angiogenesis Inhibitors - therapeutic use | Adult | Fluorescein Angiography | Severity of Illness Index | Neovascularization, Pathologic - diagnosis | Treatment Outcome | Diabetic Retinopathy - surgery | Visual Acuity | Preoperative Care | Vitreous Hemorrhage - surgery | Neovascularization, Pathologic - drug therapy | Vitreous Hemorrhage - drug therapy | Fundus Oculi | Vitreous Hemorrhage, surgery | Antibodies, Monoclonal, therapeutic use | Diabetic Retinopathy, complications | Angiogenesis Inhibitors, therapeutic use | Neovascularization, Pathologic, complications | Retinal Detachment, surgery | Diabetic Retinopathy, physiopathology | Retinal Detachment, etiology | Vitreous Hemorrhage, etiology | Neovascularization, Pathologic, diagnosis | Diabetic Retinopathy, drug therapy | Neovascularization, Pathologic, etiology | Neovascularization, Pathologic, drug therapy | Diabetic Retinopathy, surgery | Retinal Detachment, drug therapy | Vitreous Hemorrhage, drug therapy | Vascular Endothelial Growth Factor A, antagonists and inhibitors | Monoclonal antibodies | Diabetic retinopathy | Angiogenesis inhibitors | Ophthalmology | Endothelial growth factors
Journal Article
Journal Article